George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Convertible Loan Notes

20 May 2022 17:49

RNS Number : 3378M
Norman Broadbent PLC
20 May 2022
 

Norman Broadbent plc

("Norman Broadbent", "NBB" or the "Group")

Issue of Convertible Loan Notes

Norman Broadbent (AIM: NBB), a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, is pleased to announce additional investment of £400,000 by way of issue and subscription of Convertible Loan Notes ("Loan Notes").

Under the terms of a Secured Convertible Loan Note Instrument, Downing Strategic Micro-Cap Investment Trust PLC and Moulton Goodies Limited, both substantial shareholders of the Group, have each agreed to subscribe for £200,000 of secured Loan Notes to be issued on 20th May 2022.

The proceeds of the Loan Notes will be used to fund the Company's working capital and capital expenditure requirements to finance the accelerated appointments of a number of senior executives to drive the growth of the business across sectors and regions.

Principal key terms of the Loan Notes

The investment will comprise the subscription of 400,000 Loan Notes each having nominal value of £1, being in aggregate £400,000, for a period of 2 years, which can be extended at the agreement of all parties.

The Company will pay interest on the principal amount of the Loan Notes which has not been repaid or converted as follows:

1. For the period up to and including the first anniversary date (20th May 2023) at a rate of 10% per annum;

2. For the period from the first anniversary date to the date of maturity (20th May 2023 - (20thMay 2024)  at a rate of 12.5% per annum;

3. For any period beyond the maturity date at a rate of 30% per annum.

 

The Group can redeem the Loan Notes at any time, subject to a redemption fee of 2.5% in the first year and 10% thereafter. The Loan Notes are only convertible after the first anniversary date at the Loan Note holders sole option, and a maximum of 50% of the principal amount of Loan Notes outstanding plus any compounded interest unpaid can be converted to equity at a conversion value of 7 pence per Ordinary Share.

 

Related Party Transaction

Downing Strategic Micro-Cap Investment Trust PLC and Moulton Goodies Limited are both substantial shareholders of the Group and therefore are classified as related parties under the AIM Rules. The directors of the Group having consulted with WH Ireland as the Company's nominated adviser, consider that the terms of the Loan Notes are fair and reasonable insofar as the Company's shareholders are concerned.

Final 2021 Results and Annual Accounts

Following completion of this Convertible Loan Note Issue, the Group will announce its 2021 final results and annual accounts on or around 23rd May 2022.

 

Kevin Davidson, CEO of NBB, commented: "We are delighted to announce this convertible funding which will allow us to accelerate the growth of our fee earning team which has gathered real momentum in 2022. We would like to thank Downing and Moulton Goodies for their continued support as we expand the business and invest in new high performing talent."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For further information, please contact:

Norman Broadbent plc +44 (0) 20 7484 0000

Kevin Davidson

Peter Searle

Steve Smith

WH Ireland Limited +44 (0) 20 7220 1666

Jessica Cave

Darshan Patel

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURSNRUBUVUAR
Date   Source Headline
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase
23rd Aug 20227:00 amRNSDirectorate Change
16th Aug 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSChange of Adviser
20th Jul 20224:08 pmRNSDirector/PDMR Dealing
11th Jul 20227:00 amRNSTrading Update
29th Jun 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:14 pmRNSResult of AGM
7th Jun 20228:59 amRNSHolding(s) in Company
25th May 20227:00 amRNSFinal 2021 Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.